The authors prepared and tested press-coated tablets with various weight ratios of ethylcellulose to hydroxypropylcellulose (HPC) and various ratios of two different batches of HPC as an outer coating ...

REDWOOD CITY, Calif., Dec. 11, 2020 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment ...

Between April 2005 and December 2005, 216 patients (142 inpatients and 74 outpatients) from ten hospitals were enrolled. There were 126 male and 90 female patients (a ratio of 1.4:1). Of the 216 ...

Company expects controlled-release gliclazide tablets to generate $15 million in annual revenues BEIJING, Oct. 19 /PRNewswire-Asia-FirstCall/ -- Lotus Pharmaceuticals, Inc. (OTC Bulletin Board: LTUS) ...

Research examined the effects of varying excipient and polymer weight in coatings designed to optimize the release of diclofenac sodium. The goal was to release it at night to improve the treatment of ...

Modern biomedical applications and drug delivery have paved the way for controlled release technologies in the healthcare industry. This paper details the nuances of controlled release systems, ...

New Delhi: Researchers at Indian Institute of Technology Hyderabad have developed a method to produce controlled-release oral tablets by loading the drug molecules onto a base that dissolves gradually ...

Soleno intends to submit plans to FDA to conduct further analyses of clinical data from completed and ongoing studies of DCCR, together with external, natural history studies REDWOOD CITY, Calif., Dec ...

Table 2. Change in Mean Pain Score After Treatment With Controlled-release Oxycodone Tablet Formulation in Patients With Moderate to Severe Cancer Pain 1 Medical Oncology Department, Sir Run Run Shaw ...